1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10
EUROPEAN JOURNAL OF CANCER（2015）
关键词
bevacizumab,adjuvant treatment,breast cancer,normal breast cancer,cyclophosphamide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要